Solid forms of a modulator of hemoglobin
US-12473277-B2 · Nov 18, 2025 · US
This page is not indexed by search engines while we improve data quality.
Parent Stephan D patents
Parent Stephan D is listed as an inventor on 28 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Parent Stephan D |
| Total patents | 28 |
| First publication | Sep 20, 2016 |
| Latest publication | Nov 18, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Salt forms and solvates of Mcl-1 antagonists
US-12351588-B2 · Jul 8, 2025 · US
Solid state forms
US-12252486-B2 · Mar 18, 2025 · US
Crystalline Polymorphs of the Free Base of 2-Hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
US-2025032471-A1 · Jan 30, 2025 · US
Crystalline forms and salt forms of a kinase inhibitor
US-2024300897-A1 · Sep 12, 2024 · US
Crystalline forms and salt forms of a kinase inhibitor
US-12017995-B2 · Jun 25, 2024 · US
Solid forms of a modulator of hemoglobin
US-2024076290-A1 · Mar 7, 2024 · US
Solid forms of a modulator of hemoglobin
US-11851424-B2 · Dec 26, 2023 · US
Crystalline thiocholesterol
US-2023365618-A1 · Nov 16, 2023 · US
Crystalline sodium cholesteryl sulfate
US-2023365619-A1 · Nov 16, 2023 · US
Recent patents
Latest publications not already listed above.
Salt forms and solvates of mci-1 antagonists
US-2023312602-A1 · Oct 5, 2023 · US
Crystalline and liquid crystalline 25-hydroxy-cholest-5-en-3-sulfate sodium and methods for preparing same
US-2023056273-A1 · Feb 23, 2023 · US
Salt Forms of a Kinase Inhibitor
US-2023052703-A1 · Feb 16, 2023 · US
Crystalline Forms and Salt Forms of a Kinase Inhibitor
US-2023029213-A1 · Jan 26, 2023 · US
Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
US-2022395492-A1 · Dec 15, 2022 · US
Solid forms of a modulator of hemoglobin
US-2022363674-A1 · Nov 17, 2022 · US
Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
US-11452720-B2 · Sep 27, 2022 · US
Salt and crystal form of compound having agonistic activity to s1p5 receptor
US-2022289675-A1 · Sep 15, 2022 · US
Solid state forms
US-2022235045-A1 · Jul 28, 2022 · US
Solid forms of a kynurenine-3-monooxygenase inhibitor
US-11173156-B2 · Nov 16, 2021 · US
Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
US-2021161876-A1 · Jun 3, 2021 · US
Solid forms of a kynurenine-3-monooxygenase inhibitor
US-2020397782-A1 · Dec 24, 2020 · US
Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
US-10722502-B2 · Jul 28, 2020 · US
Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
US-2019255031-A1 · Aug 22, 2019 · US
Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
US-10137118-B2 · Nov 27, 2018 · US
Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
US-2018289686-A1 · Oct 11, 2018 · US
Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
US-2016346263-A1 · Dec 1, 2016 · US
Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
US-9447071-B2 · Sep 20, 2016 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Global Blood Therapeutics Inc | 14 |
| Amgen Inc | 4 |
| Exelixis Inc | 4 |
| Durect Corp | 3 |
| Chdi Foundation Inc | 2 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07B2200/13 | 26 |
| A61P35/00 | 18 |
| A61P7/06 | 14 |
| C07D401/04 | 10 |
| A61K31/4439 | 10 |